Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Livia Vavrusova"'
Autor:
Oleg S. Chaban, Celine Gruget, Christian de Bodinat, Antti Ahokas, A. Avedisova, F. Picarel-Blanchot, Marek Jarema, Dan J. Stein, Valérie Olivier, Livia Vavrusova
Publikováno v:
European Neuropsychopharmacology. 27:526-537
Agomelatine is efficacious in reducing symptoms and preventing relapse in placebo-controlled trials in generalised anxiety disorder (GAD). Nevertheless, fixed dose studies of agomelatine in GAD have not been undertaken. To determine the minimally eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b68c66cbd85faa0081206b315846c69
https://doi.org/10.1016/j.euroneuro.2017.02.007
https://doi.org/10.1016/j.euroneuro.2017.02.007
Autor:
Andreas Heinz, Livia Vavrusova, Wolfgang Gaebel, Sue Bailey, T. Kurimay, Norman Sartorius, Philip Gorwood, Silvana Galderisi, Julian Beezhold, Cécile Hanon, Rutger Jan van der Gaag, Geert Dom, Jan Wise, Danuta Wasserman
Publikováno v:
European Psychiatry, 51, 87-89
European psychiatry
European Psychiatry, 51, pp. 87-89
European psychiatry
European Psychiatry, 51, pp. 87-89
Contains fulltext : 194261.pdf (Publisher’s version ) (Closed access)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bd710a5798fb3438cff56624543c586
https://pubmed.ncbi.nlm.nih.gov/29885750
https://pubmed.ncbi.nlm.nih.gov/29885750
Autor:
Sergey Mosolov, F. Picarel-Blanchot, Valérie Olivier, Livia Vavrusova, Antti Ahokas, István Bitter, Michael Bauer, Sophie Matharan, Dan J. Stein, Jon Paul Khoo, Marek Jarema, Michael Van Ameringen, Cyril Hӧschl, Christian de Bodinat
Publikováno v:
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 28(8)
Treatment of severely symptomatic patients with generalized anxiety disorder (GAD) raises particular concerns for clinicians. This 12-week double-blind study evaluated the efficacy of agomelatine (25–50 mg/day) in the treatment of patients with sev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27c53ffb1887872f8e49be292614a456
https://pubmed.ncbi.nlm.nih.gov/30135032
https://pubmed.ncbi.nlm.nih.gov/30135032
Autor:
Monika, Szkultecka-Dębek, Katarzyna, Miernik, Jarosław, Stelmachowski, Miro, Jakovljević, Vlado, Jukić, Kaire, Aadamsoo, Sven, Janno, István, Bitter, Judit, Tolna, Marek, Jarema, Slobodan, Jankovic, Jan, Pecenak, Livia, Vavrusova, Rok, Tavčar, Jacek, Walczak, Darren, Talbot, Joanna, Augustyńska
Publikováno v:
Psychiatria Danubina. 28(2)
Schizophrenia is a serious public health problem and is ranked among the most disabling diseases in the world. The sub-study presented here was part of a larger project to characterize the burden of schizophrenia on healthcare systems and on individu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ff99cb97a666c880b1fe5736dd65c3b3
https://pubmed.ncbi.nlm.nih.gov/27287783
https://pubmed.ncbi.nlm.nih.gov/27287783
Autor:
F. Picarel-Blanchot, A. Ahokas, Valérie Olivier, Livia Vavrusova, C. De Bodinat, Oleg S. Chaban, A. Avedisova, Dan J. Stein, Marek Jarema, Celine Gruget
Publikováno v:
European Neuropsychopharmacology. 26:S601-S602
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f74821dfe75c5c51f72c3dbdb9a22e17
https://doi.org/10.1016/s0924-977x(16)31678-9
https://doi.org/10.1016/s0924-977x(16)31678-9
Autor:
Michael Bauer, Sophie Matharan, Marek Jarema, Cyril Höschl, Antti Ahokas, Sergey Mosolov, Dan J. Stein, István Bitter, Jon Paul Khoo, F. Picarel-Blanchot, D.M. Van Ameringen, Valérie Olivier, Livia Vavrusova
Publikováno v:
European Neuropsychopharmacology. 27:S1003
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8d26e27eac8c6b816c877ec967bd651
https://doi.org/10.1016/s0924-977x(17)31762-5
https://doi.org/10.1016/s0924-977x(17)31762-5